196 related articles for article (PubMed ID: 24316555)
1. Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.
Wang Z; Zhang Y; Liu Y; Wang L; Zhao L; Yang T; He C; Song Y; Gao Q
J Immunother; 2014 Jan; 37(1):43-50. PubMed ID: 24316555
[TBL] [Abstract][Full Text] [Related]
2. MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.
Wang Z; Liu Y; Zhang Y; Shang Y; Gao Q
Oncotarget; 2016 Jan; 7(4):4760-9. PubMed ID: 26716894
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma.
Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R; Guo T
Cancer Biother Radiopharm; 2010 Aug; 25(4):465-70. PubMed ID: 20701541
[TBL] [Abstract][Full Text] [Related]
4. Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma.
Zhao X; Zhang Z; Li H; Huang J; Yang S; Xie T; Huang L; Yue D; Xu L; Wang L; Zhang W; Zhang Y
Cancer Lett; 2015 Jul; 362(2):192-8. PubMed ID: 25843292
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy.
Mai HX; Mei GH; Zhao FL; Li BT; Tang YY; Zhang B; Xu XJ; Chen LJ
J Cancer Res Ther; 2018 Jun; 14(Supplement):S427-S432. PubMed ID: 29970701
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic efficacy of dendritic cells pulsed by autologous tumor cell lysate in combination with CIK cells on advanced renal cell carcinoma].
Wang H; Feng F; Zhu M; Wang R; Wang X; Wu Y; Zhuang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):67-71. PubMed ID: 25575061
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of postoperative tumor lysate-pulsed dendritic cells and cytokine-induced killer cells immunotherapy in patients with localized and locally advanced renal cell carcinoma.
Zhan HL; Gao X; Pu XY; Li W; Li ZJ; Zhou XF; Qiu JG
Chin Med J (Engl); 2012 Nov; 125(21):3771-7. PubMed ID: 23106871
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
9. Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis.
Wang ZX; Li JL; Cao JX; Liu YS; Li D; Zhang XY; Wang M; Wu M; Xu BL; Liu JL; Wang HB
Immunotherapy; 2014; 6(6):787-95. PubMed ID: 25186607
[TBL] [Abstract][Full Text] [Related]
10. Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimen.
Yang Y; Lin H; Zhao L; Song Y; Gao Q
Immunotherapy; 2017 Jun; 9(8):629-635. PubMed ID: 28653574
[TBL] [Abstract][Full Text] [Related]
11. Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma.
Liu L; Zhang W; Qi X; Li H; Yu J; Wei S; Hao X; Ren X
Clin Cancer Res; 2012 Mar; 18(6):1751-9. PubMed ID: 22275504
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in metastatic brain tumor patients.
Li W; Wang Y; Zhao L; Xu L; Zhang Y; Mai L; Gao Q
Oncol Res Treat; 2015; 38(4):160-5. PubMed ID: 25877939
[TBL] [Abstract][Full Text] [Related]
13. High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.
Zhao L; Li T; Song Y; Yang Y; Ma B; Zhang Y; Shang Y; Xu B; Guo J; Qin P; Han L; Fu X; Lin H; Liu L; Ren X; Wang Z; Gao Q
Front Immunol; 2021; 12():779248. PubMed ID: 35058923
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.
Schmidt-Wolf IG; Finke S; Trojaneck B; Denkena A; Lefterova P; Schwella N; Heuft HG; Prange G; Korte M; Takeya M; Dorbic T; Neubauer A; Wittig B; Huhn D
Br J Cancer; 1999 Nov; 81(6):1009-16. PubMed ID: 10576658
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant dendritic cells vaccine combined with cytokine-induced-killer cell therapy after renal cell carcinoma surgery.
Zheng K; Tan JM; Wu WZ; Qiu YM; Zhang H; Xu TZ; Sun XH; Zhuo WL; Wang D; Zhang JP
J BUON; 2015; 20(2):505-13. PubMed ID: 26011343
[TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma.
Kim JS; Chung IS; Lim SH; Park Y; Park MJ; Kim JY; Kim YG; Hong JT; Kim Y; Han SB
Arch Pharm Res; 2014 May; 37(5):559-66. PubMed ID: 24691830
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.
Negrier S; Maral J; Drevon M; Vinke J; Escudier B; Philip T
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S93-8. PubMed ID: 10685667
[TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy with autologous cytokine-induced killer cells in patients with advanced epithelial ovarian cancer after first-line treatment.
Liu J; Li H; Cao S; Zhang X; Yu J; Qi J; An X; Yu W; Ren X; Hao X
J Immunother; 2014; 37(2):115-22. PubMed ID: 24509174
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of large doses of IL-2-activated human leukocyte antigen haploidentical peripheral blood stem cells on refractory metastatic renal cell carcinoma.
Cao S; Wang YL; Ren XB; Yu JP; Ren BZ; Zhang XW; Zhang WH; Han Y
Cancer Biother Radiopharm; 2011 Aug; 26(4):503-10. PubMed ID: 21812652
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
